deuterium has been researched along with pioglitazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeWitt, S; Hallakou-Bozec, S; Jacques, V; Kaur, N; Klett, E; Moller, DE; Monternier, PA; Nagaraja, TN; Parasar, P; Singh, J; Theurey, P | 1 |
| Bedossa, P; Bolze, S; Cusi, K; Dewitt, S; Dubourg, J; Fouqueray, P; Grouin, JM; Hallakou-Bozec, S; Harrison, SA; Moller, DE; Ratziu, V; Thang, C | 1 |
1 trial(s) available for deuterium and pioglitazone
| Article | Year |
|---|---|
Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1).
Topics: Deuterium; Diabetes Mellitus; Double-Blind Method; Fibrosis; Humans; Liver; Non-alcoholic Fatty Liver Disease; Pioglitazone; PPAR gamma | 2023 |
1 other study(ies) available for deuterium and pioglitazone
| Article | Year |
|---|---|
Therapeutic potential of deuterium-stabilized (R)-pioglitazone-PXL065-for X-linked adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Animals; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Deuterium; Fatty Acids; Fatty Acids, Nonesterified; Inflammation; Mice; Mice, Knockout; Pioglitazone; PPAR gamma | 2022 |